Table 4.
Variables | Total (n = 182) | Low (n = 91) | High (n = 91) | P-value |
---|---|---|---|---|
Age (years), n (%) | <0.001 | |||
<60 | 112 (62) | 69 (76) | 43 (47) | |
≥60 | 70 (38) | 22 (24) | 48 (53) | |
Gender, n (%) | 0.011 | |||
Female | 80 (44) | 49 (54) | 31 (34) | |
Male | 102 (56) | 42 (46) | 60 (66) | |
Grade, n (%) | <0.001 | |||
III | 62 (34) | 56 (62) | 6 (7) | |
IV | 120 (66) | 35 (38) | 85 (93) | |
IDH status, n (%) | <0.001 | |||
Wild type | 134 (74) | 47 (52) | 87 (96) | |
Mutant | 48 (26) | 44 (48) | 4 (4) | |
Chr 1p19q co-deletion, n (%) | <0.001 | |||
No | 163 (90) | 72 (79) | 91 (100) | |
Yes | 19 (10) | 19 (21) | 0 (0) | |
MGMT promoter status, n (%) | <0.001 | |||
Unmethylated/Unknown | 94 (52) | 32 (35) | 62 (68) | |
Methylated | 88 (48) | 59 (65) | 29 (32) | |
Chemotherapy, n (%) | 0.148 | |||
No | 39 (21) | 15 (16) | 24 (26) | |
Yes | 143 (79) | 76 (84) | 67 (74) | |
Radiotherapy, n (%) | 0.568 | |||
No | 34 (19) | 19 (21) | 15 (16) | |
Yes | 148 (81) | 72 (79) | 76 (84) |